individuals with bipolar disorder (BD) may experience continued disability, due in part to lack of treatment intervention, which could potentially limit their functioning and productivity and also decrease overall quality of life for them and their families.
The World Health Organization (WHO) has ranked BD as the 12th leading cause of disability worldwide, and the worldwide prevalence of moderate or severe disability for BD is estimated at approximately 22 million individuals. 4 Poor functioning is considered a key driver of disability in patients with BD. 5 The WHO International
Classification of Functioning, Disability, and Health describes functioning and disability as multidimensional concepts involving the ability to control physical functions; perform activities related to domains such as self-care and domestic, occupational, social, and civic life; engage in all aspects of life; and manage aspects of the environment that help or hinder these experiences. 6, 7 Patients with BD report a variety problems in work functioning, 8 with severe work impairment during a considerable portion of their long-term course of illness, 9 and high unemployment rates. 10 They have decreased social engagement, 11 weaker family relationships, 12 and an increased likelihood of being separated, divorced, or widowed. 13 For many patients with BD, these functional impairments persist into symptomatic remission, leading to difficulties in many aspects of their lives. 14, 15 The negative effects of BD extend to caregivers, who report substantial burden and distress involving relationships and day-to-day activities. 16 Thus, for many patients with BD and their families, functional outcome, measured as the ability to fulfill role expectations in all aspects of life and maintain interpersonal relationships, is at times more important than syndromal outcome. 17 Although most interventional studies in patients with BD have focused on symptoms, recurrences, and mood states as the primary outcome variable, increasingly, studies are also assessing functioning as a key outcome. 17 In addition, numerous studies have sought to identify determinants of functional outcome in patients with BD.
A variety of correlates of poor functional outcome have been identified, including clinical factors such as lack of treatment adherence, comorbid substance abuse or anxiety disorder, and subsyndromal symptoms; demographic variables such as older age, male sex, and low socioeconomic status; and cognitive dysfunction, particularly verbal memory impairment and executive dysfunction. 5 The growing interest in the relationship between cognitive and psychosocial function in BD is reflected in several recent reviews on this topic 6, [17] [18] [19] and compels a better understanding of the tools used for functional assessment in this population. The purpose of this systematic literature review was to identify and describe scales that are used to assess functioning in studies of patients with BD and to gain an understanding of the domains of function that clinicians are measuring.
| ME THODS

| Information sources and eligibility criteria
This systematic literature review was conducted according to the recommendations outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. 20 A search was performed in BIOSIS Previews, Embase, and MEDLINE for English-language articles published in peer-reviewed journals between 1 January 2000 and 6 November 2017. The following search string was applied using the abstract and title as search fields:
("functional impairment" OR "psychosocial outcome" OR "psychosocial functioning" OR "psychosocial treatment" OR "psychosocial impairment" OR "occupational function" OR "occupational impairment" OR "occupational" or "functional disability" OR "psychosocial disability" OR "disability or work" OR "cognition" OR "social cognition" OR "stress" OR "functional remediation" OR "cognitive remediation") AND ("functional recovery" OR "functional outcome" OR "outcome n/1 [patient or recovery]" AND ("bipolar disorder" OR "bipolar I disorder" OR "bipolar II disorder" OR mania OR manic OR "bipolar mania" OR "bipolar depression" OR "bipolar I disorder" OR "manic psychosis" OR "bipolar disorder" OR "affective disorders, psychotic") AND (scale* OR measure*). Conference publications (ie, posters, summaries, and abstracts), review articles, notes, letters, book chapters, interactive tutorials, or surveys; publications involving animal or in vitro studies; and publications on pediatric populations were excluded.
| Article selection process
The title and abstract of each retrieved article were independently screened against eligibility criteria by one author. Selected full-text articles were then divided between the authors for detailed review and inclusion assessment. Figure 1 shows the article selection process.
| RE SULTS
| Article selection
The search retrieved 104 articles; 30 were determined ineligible based on screening of titles and abstracts, and 74 were selected for full-text review. Forty articles met the eligibility criteria and were included in the qualitative data analysis (Figure 1 ).
| Risk of publication bias
Several authors and research groups authored multiple articles identified in this review (Table 1 and Table 2 ), indicating the potential for publication bias.
| Overview of selected studies
The eligible articles included 20 cross-sectional studies (50%, 20/40; 
| Cross-sectional studies
Of the 20 cross-sectional studies included in this review, 9 (all published between 2002 and 2016) used the GAF as the sole functioning scale. 27, 28 Four of these studies compared overall functioning between patients with euthymic BP-I or BP-II vs healthy controls, 27, 32, 33 and four compared functioning between BP-I, BP-II, and/or healthy controls or between patients with BP-I and BP-II with different mood states (ie, depression, major depression, mania, hypomania, and euthymia) or functioning (ie, low vs high). [29] [30] [31] The remaining study 28 used the GAF to compare functioning in patients with euthymic BD and patients with schizophrenia. Eight 27, 28 of these nine studies that used only the GAF to measure psychosocial functioning evaluated the association between psychosocial functioning and ≥1 cognitive domain (eg, attention, learning and memory, executive function, language).
Five of these studies also assessed correlations between the GAF and demographic 27, 31 and/or clinical variables, 27,28 such as duration of illness, number of hospitalizations, number and type of episodes, symptom type and severity, and medications. One study also evaluated the relationship between psychosocial functioning and theory of mind, the ability to perceive other people's mental states. 27 The ninth study 35 used the GAF to assess functioning and symptoms in patients with BD.
In addition to these nine studies using only the GAF, one study 36 used the GAF along with the Self-reported Social Functioning Scale 
1983
The ISEL includes the following four subscales: tangible assistance (perceived availability of material aid), appraisal (perceived availability of someone to talk about one's problems), self-esteem (perceived ability of a positive comparison when comparing one's self to others), and belonging (perceived availability of people with whom one can do things)
(3)
Self-reported Self-reported Social Functioning Scale 37 (SFS)
1990
The SFS assesses the areas of functioning that are crucial to the community maintenance of individuals with schizophrenia. It provides a detailed assessment of strengths and weaknesses of individuals in comparison with reference groups based on the following seven functional domains: social engagement/withdrawal, interpersonal behavior, prosocial activities, recreation, independence-competence, independence-performance, and employment/occupation 1 (3)
Work and Social Adjustment Scale 47 (WSAS)
2002
The WSAS is a short self-report questionnaire that measures work and social adjustment on the following five domains: work ability, home management, social leisure activities, private leisure activities, and the ability to form and maintain close relationships The MVSI assesses the level of vocational functioning in a range from full-time, competitive employment at the expected level to total vocational disability; the MLCI records nine living situations ranging from head of household to hospitalization 1 (3) a Global scales.
TA B L E 3 (Continued)
(SFS) 37 to explore the relationships between executive functioning and both global functioning (GAF) and domain-specific functioning (SFS; ie, withdrawal, interpersonal behavior, prosocial activities, recreation, independence-performance, independence-competence, and employment/occupation) in patients with euthymic BP-I.
Six cross-sectional studies 38, 39 used the FAST to assess functioning; all were published between 2010 and 2017. Five of these studies assessed domain-specific functioning (ie, autonomy, occupational functioning, cognitive functioning, financial issues, interpersonal relationships, and leisure time) in patients with BP-I vs healthy controls, 38, 39 in patients with BP-I and BP-II in remission, 40, 43 43 or demographic variables 40 or to assess overall and domain-specific functioning in different mood states. 42 The sixth study that used only the FAST to assess psychosocial functioning 41 compared overall functioning in healthy controls and patients with BP-I or BP-II and assessed the relationship to cognitive functioning and depression severity. In addition to the six studies using only the FAST, one study 22 used the GAF to assess the validity of the Spanish-language version of the FAST as a new functional scale in patients with BD.
The remaining three cross-sectional studies 44, 45 used functional scales other than the GAF and the FAST. One study 46 used the RSI and VSI to assess the relationship between functional recovery and demographic, neurocognitive, and clinical factors in patients with BP-I or BP-II who were euthymic or had residual depression.
Another study 45 Five studies assessed functioning using only the FAST scale. Two of the studies 49, 53 and BP-II 6 months after an acute episode or subsyndromal state 51 and in patients with BP-I, BP-II, and BD not otherwise specified after first or multiple affective episodes. 52 The two observational studies that used both the GAF and the Five studies (published between 2005 and 2010) 58, 59 used functional scales other than the GAF and the FAST to assess functioning in patients with various psychiatric disorders. One of these studies 59 assessed the relationships between overall functioning using the LGOS, work disability/social adjustment using the SCOS, neurocognitive performance, and depressive symptoms in patients with BP-I 15 years after an index manic episode. Similarly, the LGOS and SCOS were used in a second study 60 to evaluate global functioning and work performance/social adjustment, respectively, in patients with bipolar mania, unipolar nonpsychotic depression, and unipolar psychotic depression followed for up to 8 years after an index epi- 
| Longitudinal observational studies
| Longitudinal interventional studies
Five longitudinal interventional studies 66, 67 ( BD and an increasing demand for objective and domain-specific scales that can address specific areas of interest such as cognition. 39 The results of this systematic literature review show that the GAF was the most frequently used scale in cross-sectional studies and the second most frequently used scale in longitudinal studies.
After its introduction for use in the Diagnostic and Statistical Manual of Mental Disorders (DSM), Third Edition in 1980, 76 the GAF gained widespread use and is now the most widely used clinician rating scale of disability. 77 Although this literature review did not account for studies before 2000 and after the introduction of the GAF, there are several early studies that utilized the GAF, which likely set precedence for its use in later longitudinal and cross-sectional studies.
One key study used the GAF along with the MVSI and MLCI to measure global functioning, occupational status, and residential status, respectively, over 4 years 78 in patients with BD; the aim of the study was to identify factors contributing to long-term outcomes.
The reliability and validity of the GAF, however, depend on the rater's training and expertise, and GAF scores have been observed to correlate more with symptom severity than functional impairment. 79 The FAST was introduced in 2007 as a simple interview to assess the following 6 domains of functioning considered to be the main problem areas for patients with mental illness, including BD:
autonomy, occupational functioning, cognitive functioning, finances, interpersonal relationships, and leisure time. 22 cognition, mobility, self-care, getting along, life activities, and participation, for clinical evaluation of disability. 82 We see the adoption of the WHODAS as a valuable addition to the field as it provides more specific measures of functioning. On the other hand, the GAF provides an overall rating that includes functioning which in some cases may be useful because of its ease of use. As with any scale, investigators will need to decide which scale best meets their needs. This systematic review has several limitations. Although the search parameters were designed to be comprehensive, it omitted nonEnglish articles and articles published before 2000, which could have limited its scope. In several areas of the literature, particularly studies using the GAF and FAST, multiple studies were published by the same research groups or authors at the same institutions. Although an effort was made to omit duplicate publications, it is important to recognize the potential for bias due to multiple publications by the same investigators.
In conclusion, this review shows high utilization of the GAF and 
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